The Independent Ethics Committee (IEC) of Genebandhu was constituted in 2015 under the umbrella of the "Office for Human Research and Protections" of the United States Department of Health & Human Services. Genebandhu Ethics committee is recognized as a registered body by the Drug Controller General of India (DCGI) under the Central Drugs Standard Control Organization, Government of India. The purpose of the IEC is to protect human subjects through ensuring highest ethical standards and conduct in all research carried out under the aegis of Genebandhu.
To customize appropriate guidelines based on established ethical principles, relevant scientific and legal expertise, balanced age, gender, ethnic distribution and lay person's point of view.
To provide ethical guidelines, monitor and implement ethical decisions to promote and safeguard dignity and rights of the subject.
To fill the gap and support ethical research by individuals, qualified and competent professionals as well as at mid and small sized organisations which are not sizeable enough to have their independent ethical committees.
To ensure the patient rights are fully and completely protected while clinical research is conducted with the aim and objective of collating, compiling, analysing and evaluating scientific findings and data thereby helping the society at large.
Accredited by Central Licensing Authority, CDSCO
Register: Provide personal and project related details
Submit: Email the complete proposal, along with the supporting documents
Schedule: Select a convinient date for defending your proposal
Present: Desccribe your proposal in front of an experienced and diverse panel
Learn: Modify your proposal based on the panel's suggestions.
Recieve: Download your certificate
10+ projects reviewed by our committee
Social Franchising Case Studies in India and Uganda
The Direct, Indirect and Psychosocial Costs Experienced by Caregivers of Children Being Treated for Cancer in New Delhi, India s
Children’s Participation in Health-Related Decisions in a Paediatric Oncology Setting in New Delhi, India
Analysis of Stable Isotopes and Socioeconomic Status of New Delhi Population
Exploring Barriers to Accessing Care during Treatment of Childhood Cancers in India: A Qualitative Study
Assessing essential medicines for treating childhood cancers in India
Study of Human Leukocyte Antigen (HLA)-B Allele Frequency in the Population of North India
A Prospective Pilot Study to Determine the Costs Incurred by Families of Children Newly Diagnosed with Cancer in India
Accessing Childhood Cancer Services in India (ACCESS India)
Study of HLA association with Acute Leukemia: An Indian perspective
Revised Study - Accessing Childhood Cancer Services in India – ACCESS India
Phase-II, Open-Label Randomized Clinical Trials with Optimized Dosage of Lyophilized COVID-19 Antibody-rich Plasma (L- CARP)
Published data that is reviewed and approved by our ethics committe
Neha Faruqui et al
A health care labyrinth: perspectives of caregivers on the journey to accessing timely cancer diagnosis and treatment for children in India
Shivani Ahuja et al
A pilot study to determine out‐of‐pocket expenditures by families of children being treated for cancer at public hospitalsin New Delhi, India
Stephanie Mardakis et al
A qualitative study of the costs experienced by caregivers of children being treated for cancer in New Delhi, India
Neha Faruqui et al
Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India
R. Arora et al
Families Of Children Newly Diagnosed With Cancer Incur Significant Out-Of-Pocket Expenditure For Treatment – Report Of A Multi-Site Prospective Longitudinal Study From India (InPOG-ACC-16-01)
Vikash Chandra Mishra et al
Frequency analysis of HLA-B allele in leukemia patients from a North Indian population: A case-control study
Hina Solanki et al
Human Leukocyte Antigen Associations with Acute Leukemia: An Indian Perspective
Our team consists of people specializing in various arenas to give a wider scope of perspective for the matter being discussed. They are reputed members who give their opinion without being biased or irrational. The members of the independent Ethical Committee are kept as diverse as possible to ensure multiple perspectives that are obtained on every issue being discussed in the committee. To come up with a decision, we need to be as broad minded as possible and every member represents a certain section of the society.
Dr. Aseem Tiwari
Dr. Vimarsh Raina
Tej Singh Chaudhary
Dr. Girish Sharma
Balaji Bhagat Singh
Dr. Amrita Bahl
Dr. Vikash Chandra Mishra
Dr. Archana Bambaroo
Dr. Praneet Kumar
Fr. Dr. Xavier Vedam
Frequently Asked Questions
GeneBandhu: Ethics Committee
209C, II Floor, Masjid Moth, South Extension-II
New Delhi - 110049
+91 98102 90945
011 4007 3808